Free Trial
NASDAQ:ELOX

Eloxx Pharmaceuticals (ELOX) Stock Price, News & Analysis

Eloxx Pharmaceuticals logo
$0.0001 0.00 (0.00%)
As of 08/4/2025 01:29 PM Eastern

About Eloxx Pharmaceuticals Stock (NASDAQ:ELOX)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
$0.00
$0.75
52-Week Range
$0.00
$0.75
Volume
219 shs
Average Volume
1,538 shs
Market Capitalization
$314.30
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ELOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ELOX Stock News Headlines

One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Eloxx Pharmaceuticals Inc (ELOX)
See More Headlines

ELOX Stock Analysis - Frequently Asked Questions

Eloxx Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2025. Since then, ELOX stock has increased by 0.0% and is now trading at $0.0001.

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) issued its quarterly earnings data on Monday, April, 3rd. The company reported ($2.92) earnings per share for the quarter, topping analysts' consensus estimates of ($2.97) by $0.05.

Shares of ELOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eloxx Pharmaceuticals investors own include Tesla (TSLA), ADMA Biologics (ADMA), Adverum Biotechnologies (ADVM), Assertio (ASRT), Fulcrum Therapeutics (FULC), Acasti Pharma (ACST) and Akebia Therapeutics (AKBA).

Company Calendar

Last Earnings
4/03/2023
Today
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELOX
CIK
1035354
Employees
30
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,143,000
Free Float
2,508,000
Market Cap
$314.30
Optionable
Not Optionable
Beta
-1,550.12

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ELOX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners